Akademibokhandeln
Jacques Zimmer, Evelyn Ullrich - Natural Killer Cells, Inbunden

Inbunden, Engelska, 2027

Natural Killer Cells

At the Forefront of Modern Immunology

Av Jacques Zimmer, Evelyn Ullrich

4169 kr

Kommande

Finns i fler format

Beskrivning
This revised second edition highlights the growing importance of natural killer (NK) cells as key contributors to immune defense and immune regulation. Their unique position between innate and adaptive immunity has made them central to current research, from understanding infection and inflammation to designing next‑generation immunotherapies. Across six parts, the book integrates fundamental NK‑cell biology with insights from disease settings and advanced experimental approaches. It shows how developmental pathways, receptor systems and repertoire diversity shape NK‑cell function, and how these cells respond and adapt in the context of viral infection, chronic inflammation and cancer. This includes emerging evidence on their roles in SARS‑CoV‑2, fungal immunity and vascular and autoimmune disorders. The volume also reveals how NK‑cell behavior differs across tissues such as the eye, lung, liver, uterus and skin, reflecting the influence of distinct microenvironments. Further chapters trace how cytokine signaling, immunometabolism and extracellular vesicles fine‑tune NK‑cell activity. A dedicated section on immunotherapy presents rapidly advancing strategies—from engineered NK‑cell lines to CAR‑NK and iPSC‑derived approaches—while the final part introduces cutting‑edge investigative methods, including organoid models, epigenetic analysis and AI‑enabled concepts for therapy design. With its coherent structure and forward‑looking scope, this reference work supports researchers and clinicians seeking to understand how NK cells are shaping modern immunology.
Produktinformation
Utforska kategorier
Mer information

Jacques Zimmer studied Medicine in Strasbourg (France) where he obtained his MD degree. After a few years of clinical work, he started a PhD thesis at the University of Strasbourg (Laboratory of Daniel Hanau (MD, DSc) and Henri de la Salle (PhD) about Natural Killer (NK) cells in human transporter associated with antigen processing (TAP) deficiency. After his PhD degree, he spent 3.5 years as a postdoctoral fellow in the Laboratory of Prof. Werner Held (PhD) at the Ludwig Institute for Cancer Research in Lausanne (Switzerland), where he investigated NK cell education and brought up, together with his colleagues, the cis interaction model of NK cell education.From October 2003 to November 2024, Dr. Zimmer was a Senior Research Scientist in Translational Immunology at the Department of Infection and Immunity (Director: Prof. Dr. med. Markus Ollert) of the Luxembourg Institute of Health (LIH), located in Esch-sur-Alzette (Luxembourg). He obtained his Habilitation in 2006, with Prof Jules A. Hoffmann, Nobel Prize Winner in 2011, as President of the jury.From 2014 to 2024, Dr. Zimmer taught immunology to Third Year Bachelor students in Life Sciences at the University of Luxembourg (UNI.lu). From 2022 to 2024, he was responsible for the organization and management of bio-clinical lectures in Hematology and Immunology in the 5th Semester of the Bachelor of Medicine at the UNI.lu.His research data, reviews and editorials, mostly dedicated to NK cells, have been published in numerous international peer reviewed journals. The publication count of Dr. Zimmer is currently at 113 contributions, with his work cited 4729 times and with an H-factor of 36 (Scopus, January 10th, 2025).He supervised or co-supervised 7 PhD theses, which were all successfully finished.Dr. Zimmer regularly reviews international manuscripts and grant applications, and he edited the first edition of the present NK cell book in 2010.Evelyn Ullrich, MD, is Professor of Cellular Immunology and head of the unit “Experimental Immunology and Cell Therapy” at Johann Wolfgang Goethe University in Frankfurt, Germany. She completed her clinical and research training in Freiburg, Erlangen and Paris and is a specialist in internal medicine and immunology. The current research of her group addresses the development of engineered personalized immune cell therapy with focus on NK cells.Currently, Evelyn Ullrich is speaker of the study group “NK cells & ILCs” of the German Society for Immunology (DgfI e.V.). She is an internationally recognized expert in this field, author, reviewer and editor of specialist journals and spokesperson of NK cell consortia funded by the German Cancer Research Center (DKTK) and as part of the Priority and Drug Development Program supported by the German Cancer Aid (Stiftung Deutsche Krebshilfe).Furthermore, she is speaker of a German Research Foundation (DFG)-funded Clinician Scientist program and the Mildred Scheel Career Center (MSNZ) in Frankfurt, which is an excellence program for promoting young scientists in cancer research.

Butikslager

Ej i lager i butik.

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.